Last reviewed · How we verify

NCT05383586

MusicHyperBrain Study With Preterm Infants and Their Parents

Status unknown NA Last updated 16 May 2023
What this trial tests

NA trial testing Creative Music Therapy in Pre-Term in 20 participants. Status unknown.

Timeline
3 November 2022
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date3 November 2022
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

Adults 32 Weeks to 36 Weeks, any sex, with Pre-Term. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inter-personal brain coupling between preterm infants, their parents and a musician during Creative Music Therapy using functional near-infrared imaging (fNIRI) hyperscanning and systemic physiology measurements

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Creative Music Therapy

Trials testing the same drug.

Other recruiting trials for Pre-Term

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05383586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing